213 related articles for article (PubMed ID: 9002765)
1. SPECT imaging with 111In-octreotide for the localization of pancreatic insulinoma.
Signore A; Procaccini E; Chianelli M; Salerno G; Iozzo P; Annovazzi A; Leonetti F; Tamburrano G; Ronga G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):111-2. PubMed ID: 9002765
[TBL] [Abstract][Full Text] [Related]
2. Topographic diagnosis and surgical treatment of insulinoma.
Chirletti P; Caronna R; Tamburrano G; Mellozzi M; Bonifacino A; Catalano C; Sammartino P; Stipa V
Chir Ital; 2000; 52(1):11-6. PubMed ID: 10832522
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative gamma probe detection of insulinoma in an elderly patient with pancreatic cystic lesions.
Rosière A; Ernst YJ; Roelants V; Vander Borght T; Michel L; Donckier JE
Clin Endocrinol (Oxf); 2002 Oct; 57(4):547-9. PubMed ID: 12354138
[TBL] [Abstract][Full Text] [Related]
4. [An occult pancreatic insulinoma: radio-guided surgery with 111-In-octreotide. A case report and review of the literature on pre- and intraoperative diagnosis].
Ressetta G; Geatti O; Pozzetto B; Sustersich M; Povolato M; Ferretti G; Leggeri A
Ann Ital Chir; 2000; 71(1):107-12; discussion 113. PubMed ID: 10829532
[TBL] [Abstract][Full Text] [Related]
5. Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
Ur E; Bomanji J; Mather SJ; Britton KE; Wass JA; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1993 May; 38(5):501-6. PubMed ID: 8101146
[TBL] [Abstract][Full Text] [Related]
6. [Usefullness of scintigraphy with somatostatin analogues in the imaging of insulinoma of the pancreas].
Owecki M; Czepczyriński R; Biczysko M; Stawny B; Drews M; Sowiński J
Pol Merkur Lekarski; 2006 Jan; 20(115):77-80. PubMed ID: 16617742
[TBL] [Abstract][Full Text] [Related]
7. Malignant insulinoma in ectopic pancreatic tissue.
Hennings J; Garske U; Botling J; Hellman P
Dig Surg; 2005; 22(5):377-9. PubMed ID: 16432300
[TBL] [Abstract][Full Text] [Related]
8. ¹¹¹In OctreoScan SPECT-MRI fusion for the detection of a pancreatic insulinoma.
Moncayo VM; Martin DR; Sarmiento JM; Zbytek B; Fox T; Schuster DM
Clin Nucl Med; 2012 Mar; 37(3):e53-6. PubMed ID: 22310271
[No Abstract] [Full Text] [Related]
9. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.
Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A
Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936
[TBL] [Abstract][Full Text] [Related]
10. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging.
Schillaci O; Massa R; Scopinaro F
J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Breeman WA; van Hagen PM; Kwekkeboom DJ; Visser TJ; Krenning EP
Eur J Nucl Med; 1998 Feb; 25(2):182-6. PubMed ID: 9473268
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic echo-endoscopy and preoperative localization of insulinomas].
Pitre J; Soubrane O; Dousset B; Palazzo L; Chapuis Y
Ann Chir; 1998; 52(4):369-73. PubMed ID: 9752472
[TBL] [Abstract][Full Text] [Related]
13. The role of 111In-octreotide scintigraphy in the detection of APUD tumours: our experience in eighteen patients.
Borsato N; Chierichetti F; Zanco P; Rubello D; Pasquali C; Pedrazzoli S; Ferlin G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):113-5. PubMed ID: 9002766
[TBL] [Abstract][Full Text] [Related]
14. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
15. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound localization of a pancreatic insulinoma: case report and review of the localization techniques.
Hall RS; Hanley JF; Georgitis W; McNally PR
Mil Med; 1998 Dec; 163(12):853-6. PubMed ID: 9866368
[TBL] [Abstract][Full Text] [Related]
17. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
18. [Insulinoma and octreotide].
Lamberts SW; de Herder WW; Kwekkeboom DJ; Bruining HA; Krenning EP
Ned Tijdschr Geneeskd; 1992 May; 136(19):907-10. PubMed ID: 1594063
[No Abstract] [Full Text] [Related]
19. Uptake in the pancreatic uncinate process on the 111In-octreotide scintigraphy: How to distinguish physiological from pathological uptake?
Ait Boudaoud A; Verges B; Petit JM; Tatulashvili S; Cochet A; Humbert O
Nucl Med Commun; 2017 Sep; 38(9):737-743. PubMed ID: 28704340
[TBL] [Abstract][Full Text] [Related]
20. [99mTc-OCTREOTIDE in patients with neuroendocrine tumors from the GI tract].
Gómez M; Ferrando R; Vilar J; Hitateguy R; López B; Moreira E; Kapitán M; De Lima F; Agüero B; Gabriela Villegas M; Urdaneta N; Gutiérrez E; Battegazzore A; Bayardo K; Silveira A; Lago G; Páez A
Acta Gastroenterol Latinoam; 2010 Dec; 40(4):332-8. PubMed ID: 21381408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
